Recent Quarter Total Invested
$556,386
Recent Quarter Institutional Ownership Percentage
4.26%
Total Invested of Last Quarter
$613,370
Ownership Percentage of Last Quarter
4.64%
XTL Biopharmaceuticals Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| NOKED ISRAEL LTD | 11/14/2024 | 198,888 | $477,000 | 0.00% | 3.65% |
| MORGAN STANLEY | 11/14/2024 | 26,451 | $63,612 | -20.21% | 0.49% |
| RHUMBLINE ADVISERS | 11/12/2024 | 6,519 | $15,774 | 16.74% | 0.12% |
| CITADEL ADVISORS LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
XTL Biopharmaceuticals Ltd.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of XTLB shares?
During the previous two years, 5 institutional investors and hedge funds held shares of XTL Biopharmaceuticals Ltd.. The most heavily invested institutionals were:
Noked Israel Ltd: 198,888
MORGAN STANLEY: 26,451
RHUMBLINE ADVISERS: 6,519
CITADEL ADVISORS LLC: 0
Noked Capital LTD: 198,888
-
What percentage of XTL Biopharmaceuticals Ltd. stock is owned by institutional investors?
4.26% of XTL Biopharmaceuticals Ltd. stock is owned by institutional investors.
-
How much institutional buying is happening at XTLB ?
Institutional investors have bought a total of 430,746 shares in the last 24 months. This purchase volume represents approximately $809,802 in transactions.